Jonas Eriksson

Jonas Eriksson

Uppsala University - Uppsala / Sweden
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 1256069
Uppsala Universitet
person_outline Jonas Eriksson's MOST POPULAR ARTICLES
1-) Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic DrugsAAM Van der Veldt, M Lubberink, I Bahce, M Walraven, MP de Boer, ...Cancer Cell 21 (1), 82-91, 20123412012
2-) A Comparative Study of the Hypoxia PET Tracers [18 F] HX4,[18 F] FAZA, and [18 F] FMISO in a Preclinical Tumor ModelSGJA Peeters, CML Zegers, NG Lieuwes, W van Elmpt, J Eriksson, ...International Journal of Radiation Oncology* Biology* Physics 91 (2), 351-359, 20151792015
3-) Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigmK Chiotis, L Saint-Aubert, I Savitcheva, V Jelic, P Andersen, M Jonasson, ...European journal of nuclear medicine and molecular imaging 43 (9), 1686-1699, 20161332016
4-) Quantification of [18F] DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer\'s disease patientsSSV Golla, R Boellaard, V Oikonen, A Hoffmann, BNM van Berckel, ...Journal of Cerebral Blood Flow & Metabolism 35 (5), 766-772, 20151242015
5-) In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F] HX4 and [18F] FDG-PET/CT ImagingCML Zegers, W van Elmpt, B Reymen, AJG Even, EGC Troost, MC Öllers, ...Clinical Cancer Research 20 (24), 6389-6397, 20141082014